Additional file 2: Table S2. of The relation between health insurance and management of hypertension in Shanghai, China: a cross-sectional study

P-Values for the Differences Before and After Correction on the Multiple propensity score. (DOCX 15 kb

Additional file 1: Table S1. of The relation between health insurance and management of hypertension in Shanghai, China: a cross-sectional study

ORs in different outcome models. (DOCX 19 kb

Characteristics of included trials.

<p>Abbreviations: NR, not reported.</p

Identification process for eligible studies.

<p>Identification process for eligible studies.</p

Comparison of 3-year recurrence between hepatocellular carcinoma therapy and non-immunotherapy postoperation therapy.

<p>Comparison of 3-year recurrence between hepatocellular carcinoma therapy and non-immunotherapy postoperation therapy.</p

Comparison of 1-year recurrence between hepatocellular carcinomatherapy and non-immunotherapy postoperation therapy.

<p>Comparison of 1-year recurrence between hepatocellular carcinomatherapy and non-immunotherapy postoperation therapy.</p

Comparison of 3-year overall survival between hepatocellular carcinoma therapy and non-immunotherapy postoperation therapy.

<p>Comparison of 3-year overall survival between hepatocellular carcinoma therapy and non-immunotherapy postoperation therapy.</p

Comparison of overall survival between combined inhibition therapy and single inhibition therapy.

<p>Comparison of overall survival between combined inhibition therapy and single inhibition therapy.</p

Identification process for eligible studies.

<p>Identification process for eligible studies.</p

Comparison of progression-free survival between combined inhibition therapy and single inhibition therapy.

<p>Comparison of progression-free survival between combined inhibition therapy and single inhibition therapy.</p